-
1
The authors repeated their meta-analysis after the LungTIME-C01 randomized clinical trial was retracted.
-
2
Excluding the retracted trial reduced the analysis from 29 studies and 6129 patients to 28 studies and 5919 patients.
-
3
The revised pooled hazard ratio for overall survival was 0.61 (95% CI, 0.52-0.71), compared with 0.60 (95% CI, 0.51-0.70) originally.
-
4
The revised pooled hazard ratio for progression-free survival was 0.65 (95% CI, 0.57-0.74), compared with 0.62 (95% CI, 0.54-0.71) originally.
-
5
The correction updated the analyses, article sections, tables, figures, and supplementary materials, including documentation of the excluded trial.
Based on findings from:
Revised Meta-Analysis After Exclusion of Retracted Study
Jama Network Open, 2026.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2855584
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
